APRI (Aprinoia Therapeutics) Ending Cash Position: $1.58 Mil (As of Dec. 2023)


What is Aprinoia Therapeutics Ending Cash Position?

Aprinoia Therapeutics APRI Ending Cash Position is $1.58 Mil as of Dec. 2023.

Aprinoia Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was $1.58 Mil.

Aprinoia Therapeutics's quarterly Ending Cash Position increased from Dec. 2022 ($1.22 Mil) to Jun. 2023 ($7.73 Mil) but then declined from Jun. 2023 ($7.73 Mil) to Dec. 2023 ($1.58 Mil).

Aprinoia Therapeutics's annual Ending Cash Position declined from Dec. 2021 ($9.67 Mil) to Dec. 2022 ($1.22 Mil) but then increased from Dec. 2022 ($1.22 Mil) to Dec. 2023 ($1.58 Mil).

Aprinoia Therapeutics Ending Cash Position Related Terms

Aprinoia Therapeutics Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Ending Cash Position Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Ending Cash Position
9.67 1.22 1.58

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position 0.00 7.69 1.22 7.73 1.58

Aprinoia Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aprinoia Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.221+0.357
=1.58

Aprinoia Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=7.731+-6.153
=1.58

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $1.58 Mil mean?
Aprinoia Therapeutics (APRI) has a Ending Cash Position of $1.58 Mil as of Dec. 2023. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Ending Cash Position too high?
Aprinoia Therapeutics' current Ending Cash Position is $1.58 Mil.
How does Aprinoia Therapeutics' Ending Cash Position compare to ?
Aprinoia Therapeutics' Ending Cash Position of $1.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Ending Cash Position is $1.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Ending Cash Position of $1.58 Mil. The current Ending Cash Position is $1.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Ending Cash Position is $1.58 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.